Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley and Sons Ltd (on behalf of European Academy of Allergy and Clinical Immunology)
Abstract
Introduction: The MEGA (MEchanism underlying the Genesis and evolution of Asthma) project is a multicenter cohort study carried out in eight Spanish hospitals, gathering clinical, physiological, and molecular data from patients with asthma and multimorbidities in order to gain insight into the different physiopathological mechanisms involved in this disorder.
Material and Methods: We report the baseline clinical and physiological characteristics and biomarker measures of adult participants in the project with the aim of better understanding the natural history and underlying mechanisms of asthma as well as the associated multimorbidities across different levels of severity. We carried out a detailed clinical examination, pulmonary function testing, measurement of fractional exhaled nitric oxide (FeNO), blood counts, induced sputum, skin prick tests, chest computed tomography scan, asthma questionnaires, and multimorbidity assessment in 512 asthmatic patients.
Results: When compared to patients with milder disease, severe asthmatic patients showed greater presence of symptoms, more exacerbations, lower asthma control, increased airflow obstruction, and higher frequency of chronic rhinosinusitis with nasal polyps, severe rhinitis, anxiety and depression, gastroesophageal reflux, and bronchiectasis.
Conclusion: The MEGA project succeeded in recruiting a high number of asthma patients, especially those with severe disease, who showed lower control and higher frequency of multimorbidities.
Description
Keywords
Bibliographic citation
Rial MJ, Álvarez‐Puebla MJ, Arismendi E, et al. Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort. Clin Transl Allergy. 2021;11:e12001. https://doi.org/10.1002/ clt2.12001
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1002/clt2.12001Sponsors
Sanofi [02/055]
the Merck Health Foundation
CIBER de Enfermedades Respiratorias (CIBERES), a Carlos III Institute of Health initiative
FEDER funds
the Merck Health Foundation
CIBER de Enfermedades Respiratorias (CIBERES), a Carlos III Institute of Health initiative
FEDER funds
Rights
Attribution-NonCommercial-ShareAlike 4.0 International








